We explore GLP-1 analogs for weight loss, BPC-157 for wound healing and reducing inflammation, as well as peptides that increase growth hormone, improve REM sleep, and enhance cognitive function
BPC-157, in particular, has garnered attention for its potential therapeutic effects, including tissue repair, inflammation modulation, and pain reduction
Human data: caution The only human data published to date are extremely limited: a 2024 pilot trial in 12 patients with interstitial cystitis treated with 10 mg of BPC-157 injected into the bladder wall, and a 2026 pharmacokinetic study in two healthy subjects (one 58-year-old man and one 68-year-old woman) receiving intravenous BPC-157
The effects of chronic use, potential drug interactions and effects on specific populations (pregnant women, children, immunocompromised individuals) are largely unknown